0.828
0.00 (0.16%)
| Penutupan Terdahulu | 0.827 |
| Buka | 0.840 |
| Jumlah Dagangan | 114,565 |
| Purata Dagangan (3B) | 108,293 |
| Modal Pasaran | 27,419,960 |
| Harga / Buku (P/B) | 11.18 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.110 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.71% |
| Nisbah Semasa (MRQ) | 1.91 |
| Aliran Tunai Operasi (OCF TTM) | -4.91 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -3.52 M |
| Pulangan Atas Aset (ROA TTM) | -99.87% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Jupiter Neurosciences, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.5 |
| Purata | -0.88 |
|
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 54.21% |
| % Dimiliki oleh Institusi | 1.17% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 30 Jun 2025 | Pengumuman | Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery |
| 27 Jun 2025 | Pengumuman | Jupiter Neurosciences Unveils Nugevia™ GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Science |
| 23 Jun 2025 | Pengumuman | Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador |
| 16 Jun 2025 | Pengumuman | How Jupiter Neuroscience's Two-Prong Approach Could Crack The Code On Biotech Success |
| 09 Jun 2025 | Pengumuman | Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science |
| 08 Apr 2025 | Pengumuman | Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |